Stay updated on Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial

Sign up to get notified when there's something new on the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A notice about NIH website terminology changes and transition updates was added to the page.
    Difference
    0.0%
    Check dated 2026-10-22T09:49:52.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-15T13:11:29.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-08T14:48:29.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A new version 1052 posted on 2026-10-01 updates the study's Contacts/Locations and Study Status. The prior version dated 2026-08-04 was removed.
    Difference
    0.0%
    Check dated 2026-10-01T14:55:14.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page’s Revision line changes from v3.6.6 to v3.7.0, indicating a new release of the Study History page’s UI/structure without altering the underlying study data.
    Difference
    0.0%
    Check dated 2026-09-17T22:09:34.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A new Revision: v3.6.6 entry is added to the history, replacing the previous Revision: v3.6.5 entry.
    Difference
    0.0%
    Check dated 2026-09-03T18:38:25.000Z thumbnail image

Stay in the know with updates to Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page.